<DOC>
	<DOCNO>NCT02723812</DOCNO>
	<brief_summary>An open label , non-comparative bridging study evaluate safety GCFLU速 ( seasonal influenza vaccine ) administer intramuscularly healthy Vietnamese volunteer age 3 year old</brief_summary>
	<brief_title>Evaluate Safety GCFLU速 Administered Intramuscularly Healthy Vietnamese Volunteer Aged From 3 Years Old</brief_title>
	<detailed_description>A bridging study evaluate safety seasonal influenza vaccine GCFLU速 pre-filled syringe inj . One dose ( 0.5 ml ) exposure administer intramuscularly . The study conduct Ben Luc District Long An province , 120 healthy Vietnamese volunteer age 5 year old enroll study . All subject receive one dose ( 0.5 ml ) vaccine Day 0 . Study variable collect determine provide evidence safety GCFLU速 , include : - Local systemic adverse event ( AE ) 30 minute vaccination . - Local systemic AE 7 day vaccination - Unsolicited AE 21 day vaccination . - Serious adverse event ( SAE ) vaccination 21 day observation period Study protocol review approved Pasteur Institute Ho Chi Minh City ( HCMC ) Institutional Review Board ( IRB ) , Vietnam Ministry Health - Independent Ethics Committee ( IEC ) Vietnam Minister Health .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject must meet criterion participate study 1 . A person 3yearold old , healthy follow 21 day 2 . Subject give voluntary write consent participate study , able comply study requirement . With subject age 3 year 18 year , parents/legal representative give voluntary consent participate study , subject 12 18 year old give voluntary write consent child . Subject one criterion must participate study 1 . Subject know hypersensitivity allergic reaction egg eggs product , chicken chicken product , component study vaccine , neomycin gentamicin . 2 . Subjects immune system disorder include immune deficiency disease . 3 . Subjects history GuillainBarre syndrome . 4 . Subjects severe chronic disease ( e.g . ; cardiovascular disease except controlled hypertension , respiratory disease , metabolic disease , renal/kidney dysfunction hemoglobinopathy etc . ) investigator 's opinion may difficulty participate study . 5 . Subjects hemophilia receive treatment anticoagulant , increased risk serious bleed intramuscular injection . 6 . Subject acute fever body temperature exceed 37.50 Celsius ( armpit calculate ) vaccination study drug . 7 . Subjects receive vaccination within 14 day vaccination study drug , another vaccination schedule study . 8 . Pregnant woman , breastfeed woman woman childbearing potential use appropriate method contraception ( use condom , intrauterine contraceptive device , hormone contraceptive , male partner vasectomy ) . 9 . Subjects participate clinical study within 28 day prior vaccination study drug , another clinical trial schedule study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>GCFLU</keyword>
	<keyword>vaccine</keyword>
	<keyword>Vietnam</keyword>
</DOC>